US Stock MarketDetailed Quotes

VRPX Virpax Pharmaceuticals

Watchlist
  • 3.1000
  • +0.1816+6.22%
Close Apr 26 16:00 ET
3.63MMarket Cap-239P/E (TTM)

About Virpax Pharmaceuticals Company

Virpax Pharmaceuticals, Inc. is a preclinical stage biopharmaceutical company, which engages in the development of branded, non-addictive pain management products. Its products include metered-dose spray, liposomal gel encapsulates, and intranasal spray. The company was founded by Anthony P. Mack and Jeffrey A. Gudin in 2016 and and is headquartered in Berwyn, PA.

Company Profile

SymbolVRPX
Company NameVirpax Pharmaceuticals
Listing DateFeb 17, 2021
Issue Price10.00
Founded2017
CEOMr. Gerald W. Bruce
MarketNASDAQ
Employees7
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address1055 Westlakes Drive,Suite 300
CityBerwyn
ProvincePennsylvania
CountryUnited States of America
Zip Code19312
Phone1-610-727-4597
Websitehttp://www.virpaxpharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Gerald W. Bruce
  • Director and Chief Executive Officer
  • --
  • Jeffrey Gudin, M.D.
  • Executive Vice President, Chief Medical Officer and Director
  • 285.00K
  • Vinay Shah
  • Corporate Secretary, Chief Financial Officer and Principal Accounting Officer
  • --
  • Dr. Sheila A. Mathias, J.D.,M.B.A.,PhD
  • Chief Scientific Officer
  • --
  • Dr. Eric Floyd, PhD
  • Chairman of the Board
  • 71.00K
  • Jerrold Sendrow
  • Independent Director
  • 65.00K
  • Dr. Barbara Ruskin, J.D.,PhD
  • Independent Director
  • --
  • Michael F. Dubin, C.P.A.
  • Independent Director
  • 65.00K
  • Dr. Vanila M. Singh, M.D.
  • Independent Director
  • 65.00K
  • Dr. Thani Jambulingam, PhD
  • Independent Director
  • 69.00K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg